Julie C Fitzgerald1, Rajit K Basu, Ayse Akcan-Arikan, Ledys M Izquierdo, Byron E Piñeres Olave, Amanda B Hassinger, Maria Szczepanska, Akash Deep, Duane Williams, Anil Sapru, Jason A Roy, Vinay M Nadkarni, Neal J Thomas, Scott L Weiss, Susan Furth. 1. 1Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.2Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.3Division of Critical Care Medicine and the Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.4Sections of Critical Care and Renal, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.5Division of Pediatric Critical Care Medicine, Hospital Militar Central, Bogotá, Colombia.6Department of Pediatric Critical Care Medicine, Pablo Tobón Uribe Hospital, Medellín, Colombia.7Department of Pediatrics, State University of New York at Buffalo, Jacobs School of Medicine and Biomedical Sciences, and Division of Pediatric Critical Care, Women and Children's Hospital of Buffalo, Buffalo, NY.8Department of Pediatrics, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.9Paediatric Intensive Care Unit, Department of Child Health, King's College Hospital, London, United Kingdom.10Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA.11Division of Critical Care Medicine, Department of Pediatrics, University of California, San Francisco, San Francisco, CA.12Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.13Division of Pediatric Critical Care Medicine, Penn State Hershey Children's Hospital, Penn State University College of Medicine, Hershey, PA.
Abstract
OBJECTIVES: The prevalence of septic acute kidney injury and impact on functional status of PICU survivors are unknown. We used data from an international prospective severe sepsis study to elucidate functional outcomes of children suffering septic acute kidney injury. DESIGN: Secondary analysis of patients in the Sepsis PRevalence, OUtcomes, and Therapies point prevalence study: acute kidney injury was defined on the study day using Kidney Disease Improving Global Outcomes definitions. Patients with no acute kidney injury or stage 1 acute kidney injury ("no/mild acute kidney injury") were compared with those with stage 2 or 3 acute kidney injury ("severe acute kidney injury"). The primary outcome was a composite of death or new moderate disability at discharge defined as a Pediatric Overall Performance Category score of 3 or higher and increased by 1 from baseline. SETTING: One hundred twenty-eight PICUs in 26 countries. PATIENTS: Children with severe sepsis in the Sepsis PRevalence, OUtcomes, and Therapies study. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: One hundred two (21%) of 493 patients had severe acute kidney injury. More than twice as many patients with severe acute kidney injury died or developed new moderate disability compared with those with no/mild acute kidney injury (64% vs 30%; p < 0.001). Severe acute kidney injury was independently associated with death or new moderate disability (adjusted odds ratio, 2.5; 95% CI, 1.5-4.2; p = 0.001) after adjustment for age, region, baseline disability, malignancy, invasive mechanical ventilation, albumin administration, and the pediatric logistic organ dysfunction score. CONCLUSIONS: In a multinational cohort of critically ill children with severe sepsis and high mortality rates, septic acute kidney injury is independently associated with further increased death or new disability.
OBJECTIVES: The prevalence of septic acute kidney injury and impact on functional status of PICU survivors are unknown. We used data from an international prospective severe sepsis study to elucidate functional outcomes of children suffering septic acute kidney injury. DESIGN: Secondary analysis of patients in the Sepsis PRevalence, OUtcomes, and Therapies point prevalence study: acute kidney injury was defined on the study day using Kidney Disease Improving Global Outcomes definitions. Patients with no acute kidney injury or stage 1 acute kidney injury ("no/mild acute kidney injury") were compared with those with stage 2 or 3 acute kidney injury ("severe acute kidney injury"). The primary outcome was a composite of death or new moderate disability at discharge defined as a Pediatric Overall Performance Category score of 3 or higher and increased by 1 from baseline. SETTING: One hundred twenty-eight PICUs in 26 countries. PATIENTS: Children with severe sepsis in the Sepsis PRevalence, OUtcomes, and Therapies study. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: One hundred two (21%) of 493 patients had severe acute kidney injury. More than twice as many patients with severe acute kidney injury died or developed new moderate disability compared with those with no/mild acute kidney injury (64% vs 30%; p < 0.001). Severe acute kidney injury was independently associated with death or new moderate disability (adjusted odds ratio, 2.5; 95% CI, 1.5-4.2; p = 0.001) after adjustment for age, region, baseline disability, malignancy, invasive mechanical ventilation, albumin administration, and the pediatric logistic organ dysfunction score. CONCLUSIONS: In a multinational cohort of critically ill children with severe sepsis and high mortality rates, septic acute kidney injury is independently associated with further increased death or new disability.
Authors: David A Colantonio; Lianna Kyriakopoulou; Man Khun Chan; Caitlin H Daly; Davor Brinc; Allison A Venner; Maria D Pasic; David Armbruster; Khosrow Adeli Journal: Clin Chem Date: 2012-02-27 Impact factor: 8.327
Authors: Omar Alkandari; K Allen Eddington; Ayaz Hyder; France Gauvin; Thierry Ducruet; Ronald Gottesman; Véronique Phan; Michael Zappitelli Journal: Crit Care Date: 2011-06-10 Impact factor: 9.097
Authors: Julie C Fitzgerald; Michelle E Ross; Neal J Thomas; Scott L Weiss; Fran Balamuth; Amanda Hyre Anderson Journal: Pediatr Nephrol Date: 2018-06-14 Impact factor: 3.714
Authors: Robert B Lindell; Shira J Gertz; Courtney M Rowan; Jennifer McArthur; Florian Beske; Adrian Plunkett; Scott L Weiss; Neal J Thomas; Vinay M Nadkarni; Julie C Fitzgerald Journal: Pediatr Crit Care Med Date: 2017-12 Impact factor: 3.624
Authors: Natalja L Stanski; Erin K Stenson; Natalie Z Cvijanovich; Scott L Weiss; Julie C Fitzgerald; Michael T Bigham; Parag N Jain; Adam Schwarz; Riad Lutfi; Jeffrey Nowak; Geoffrey L Allen; Neal J Thomas; Jocelyn R Grunwell; Torrey Baines; Michael Quasney; Bereketeab Haileselassie; Hector R Wong Journal: Am J Respir Crit Care Med Date: 2020-04-01 Impact factor: 21.405
Authors: Scott L Weiss; Fran Balamuth; Cary W Thurm; Kevin J Downes; Julie C Fitzgerald; Benjamin L Laskin Journal: Clin J Am Soc Nephrol Date: 2019-04-18 Impact factor: 8.237
Authors: Julie E Stark; Amy M Opoka; Jaya Mallela; Prasad Devarajan; Qing Ma; Nick C Levinsky; Keith F Stringer; Hector R Wong; Matthew N Alder Journal: Am J Physiol Renal Physiol Date: 2020-02-18
Authors: Natalja L Stanski; Natalie Z Cvijanovich; Julie C Fitzgerald; Michael T Bigham; Hector R Wong Journal: Intensive Care Med Date: 2020-02-11 Impact factor: 17.440
Authors: Stephen W Standage; Shenyuan Xu; Lauren Brown; Qing Ma; Adeleine Koterba; Patrick Lahni; Prasad Devarajan; Michael A Kennedy Journal: Am J Physiol Renal Physiol Date: 2021-04-12